Pricing
Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Industries
Headquarters
Employees
Links
Org chart
Teams
Offices
Nickolay V. Kukekov
0 people · 0 jobs
HQ
Astellas Pharma
46 followers
Tilray
19 followers
Knight Therapeutics
1 follower
AstraZeneca
474 followers
Bayer
397 followers
Bristol-Myers Squibb
278 followers
UCB
71 followers
NYU Langone Health
35 followers
Perrigo
17 followers
West Pharmaceutical Services
11 followers
Dechra Pharmaceuticals
9 followers
View more